var Date1 = "7/27/10";
    var Title1 = "Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010";
    var URL1 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=492645";
  
    var Date2 = "7/21/10";
    var Title2 = "Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing";
    var URL2 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=490508";
  
    var Date3 = "5/06/10";
    var Title3 = "Amicus Therapeutics Announces First Quarter 2010 Financial Results and Product Pipeline Advancements";
    var URL3 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=467412";
  
    var Date4 = "4/28/10";
    var Title4 = "Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010";
    var URL4 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=464164";
  
    var Date5 = "3/02/10";
    var Title5 = "Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock";
    var URL5 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=448554";
  
    var Date6 = "2/25/10";
    var Title6 = "Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock";
    var URL6 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=447363";
  
    var Date7 = "2/16/10";
    var Title7 = "Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements";
    var URL7 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=445108";
  
    var Date8 = "2/11/10";
    var Title8 = "Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal(TM) for Fabry Disease";
    var URL8 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=444486";
  
    var Date9 = "2/05/10";
    var Title9 = "Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board";
    var URL9 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=443226";
  
    var Date10 = "2/04/10";
    var Title10 = "Amicus Therapeutics to Announce Fourth Quarter and Year End 2009 Financial Results on February 16, 2010";
    var URL10 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=442929";
  
    var Date11 = "1/11/10";
    var Title11 = "Amicus Therapeutics Outlines 2010 Strategic Priorities and Continued Progress with Product Pipeline";
    var URL11 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=436620";
  
    var Date12 = "1/05/10";
    var Title12 = "Amicus Therapeutics to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010";
    var URL12 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=434159";
  
    var Date13 = "11/12/09";
    var Title13 = "Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009";
    var URL13 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=423798";
  
    var Date14 = "11/03/09";
    var Title14 = "Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors";
    var URL14 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=421301";
  
    var Date15 = "10/29/09";
    var Title15 = "Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates";
    var URL15 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=420027";
  
    var Date16 = "10/26/09";
    var Title16 = "Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date";
    var URL16 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=417974";
  
    var Date17 = "10/02/09";
    var Title17 = "Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease";
    var URL17 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=413437";
  
    var Date18 = "9/30/09";
    var Title18 = "Amicus Therapeutics Announces Plan to Initiate Phase 1 Study of AT2220 for Pompe Disease";
    var URL18 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=412487";
  
    var Date19 = "8/05/09";
    var Title19 = "Amicus Therapeutics Announces Second Quarter 2009 Financial Results";
    var URL19 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=401537";
  
    var Date20 = "7/29/09";
    var Title20 = "Amicus Therapeutics Announces Second Quarter 2009 Financial Results Release Date";
    var URL20 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=399710";
  
    var Date21 = "6/22/09";
    var Title21 = "Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease";
    var URL21 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=391040";
  
    var Date22 = "5/07/09";
    var Title22 = "Amicus Therapeutics Announces First Quarter 2009 Financial Results";
    var URL22 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=382589";
  
    var Date23 = "4/30/09";
    var Title23 = "Amicus Therapeutics Announces First Quarter 2009 Financial Results Release Date";
    var URL23 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=380788";
  
    var Date24 = "3/30/09";
    var Title24 = "Amicus Therapeutics to Present at the 16th Annual Future Leaders in the Biotech Industry Conference";
    var URL24 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=373690";
  
    var Date25 = "3/28/09";
    var Title25 = "Amicus Therapeutics Presents Positive Results From Phase 2 Extension Study of Amigal(TM) for Fabry Disease at ACMG 2009 Annual Meeting";
    var URL25 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=373643";
  
    var Date26 = "3/25/09";
    var Title26 = "Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent";
    var URL26 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=372817";
  
    var Date27 = "3/11/09";
    var Title27 = "Amicus Therapeutics to Present at the Cowen and Company 29th Annual Healthcare Conference on March 17, 2009";
    var URL27 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=370138";
  
    var Date28 = "2/27/09";
    var Title28 = "Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease";
    var URL28 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=368188";
  
    var Date29 = "2/18/09";
    var Title29 = "Amicus Therapeutics Announces Change to Board of Directors";
    var URL29 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=366433";
  
    var Date30 = "2/05/09";
    var Title30 = "Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results";
    var URL30 = "http://ir.amicustherapeutics.com/ReleaseDetail.cfm?ReleaseID=363911";